Seeking Alpha

Raptor Pharmaceutical (RPTP +3.38%) moves higher after saying it's acquired exclusive rights...

Raptor Pharmaceutical (RPTP +3.38%) moves higher after saying it's acquired exclusive rights from McGill University to intellectual property related to a potential malaria treatment. With the patent, the company hopes to capitalize on promising preclinical findings on the use of cysteamine and related compounds for the treatment of malaria.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|